SLC35B2 Antibody

Sulfotransferases (e.g., SULT4A1; MIM 608359) use an activated form of sulfate, 3-prime-phosphoadenosine 5-prime-phosphosulfate (PAPS), as a common sulfate donor for sulfation of glycoproteins, proteoglycans, and glycolipids in the endoplasmic reticulum and Golgi apparatus. SLC35B2 is located in the microsomal membrane and transports PAPS from the cytosol, where it is synthesized, into the Golgi lumen (Kamiyama et al., 2003 [PubMed 12716889]).[supplied by OMIM]

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

We have publications tested in 2 confirmed species: Human, Mouse.

We have publications tested in 2 applications: IF/IHC, IHC-P.

Showing Publications 1 - 2 of 2.

Publications using NBP1-80641	Applications	Species
Zhu J, Fan Y, Xiong Y et al. Delineating the dynamic evolution from preneoplasia to invasive lung adenocarcinoma by integrating single-cell RNA sequencing and spatial transcriptomics Experimental & molecular medicine 2022-11-25 [PMID: 36434043] (IF/IHC, Human)	IF/IHC	Human
Stirling ER, Terabe M, Wilson AS et al. Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response Journal for immunotherapy of cancer 2022-11-01 [PMID: 36418073] (IHC-P, Mouse)	IHC-P	Mouse

Array NBP1-80641

• SLC35B2 Antibodies
• SLC35B2 Lysate
• SLC35B2 Proteins